Antifungal susceptibility and growth inhibitory response of oral Candida species to Brucea javanica Linn. extract

BMC Complementary and Alternative Medicine

Fathilah Abdul Razak¹  Wan Himratul Aznita Wan Harun¹  Mohd-Al-Faisal Nordin¹ 

[1] Department of Oral Biology and Biomedical Sciences, Faculty of Dentistry, University of Malaya, Kuala Lumpur 50603, Malaysia

关键词: Growth inhibitory effect;    Candida species;    Brucea javanica;    Antifungal activity;   

Others  :  1220475
DOI  :  10.1186/1472-6882-13-342

 received in 2013-05-30, accepted in 2013-11-29,  发布年份 2013

【 摘 要 】

Background

Candida species have been associated with the emergence of resistant strains towards selected antifungal agents. Plant products have been used traditionally as alternative medicine to ease candidal infections. The present study was undertaken to investigate the antifungal susceptibility patterns and growth inhibiting effect of Brucea javanica seeds extract against Candida species.

Methods

A total of seven Candida strains that includes Candida albicans ATCC14053, Candida dubliniensis ATCCMYA-2975, Candida glabrata ATCC90030, Candida krusei ATCC14243, Candida lusitaniae ATCC64125, Candida parapsilosis ATCC22019 and Candida tropicalis ATCC13803 were used in this study. The antifungal activity, minimum inhibitory concentration and minimum fungicidal concentration of B. javanica extract were evaluated. Each strain was cultured in Yeast Peptone Dextrose broth under four different growth environments; (i) in the absence and presence of B. javanica extract at respective concentrations of (ii) 1 mg/ml (iii) 3 mg/ml and (iv) 6 mg/ml. The growth inhibitory responses of the candidal cells were determined based on changes in the specific-growth rates (μ) and doubling time (g). The values in the presence of extract were computed as percentage in the optical density relative to that of the total cells suspension in the absence of extract.

Results

B. javanica seeds extract exhibited antifungal properties. C. tropicalis showed the highest growth rate; 0.319 ± 0.002 h^-1, while others were in the range of 0.141 ± 0.001 to 0.265 ± 0.005 h^-1. In the presence of extract, the lag and log phases were extended and deviated the μ- and g-values. B. javanica extract had significantly reduced the μ-values of C. dubliniensis, C. krusei and C. parapsilosis at more than 80% (ρ < 0.05), while others were reduced within the range of 2.28% to 57.05%. The g-values of most candidal strains were extended and significantly reduced (ρ < 0.05) in relative to the untreated. The candidal population was reduced from an average of 10 x 10⁶ to 6 x 10⁶ CFU/ml.

Conclusions

B. javanica extract exhibited in vitro antifungal activity against seven oral Candida species. The fungistatic and growth inhibiting effects of B. javanica extract have shown that it has potential to be considered as a promising candidate for the development of antifungal agent in oral health products.

【 授权许可】

   
2013 Nordin et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】

• [1]Fleming RV, Walsh TJ, Anaissie EJ: Emerging and less common fungal pathogens. Infect Dis Clin North Am 2002, 16:915-933.
• [2]He XY, Meurman JH, Kari K, Rautemaa R, Samaranayake LP: In vitro adhesion of Candida species to denture base materials. Mycoses 2006, 49:80-84.
• [3]Ramage G, Martinez JP, Lopez-Ribot JL: Candida albicans on implanted biomaterials: a clinically significant problem. FEMS Yeast Res 2006, 6:979-986.
• [4]Resende JC, Franco GR, Rosa CA, Hahn RC, Hamdan JS: Phenotypic and genotypic identification of Candida spp. isolated from hospitalized patients. Rev Iberoam Micol 2004, 21:24-28.
• [5]Sánchez-Vargas LO, Ortiz-López NG, Villar M, Moragues MD, Aguirre JM, Cashat-Cruz M, Lopez-Ribot JL, Gaitán-Cepeda LA, Quindós G: Point prevalence, microbiology and antifungal susceptibility patterns of oral Candida isolates colonizing or infecting Mexican HIV/AIDS patients and healthy persons. Rev Iberoam Micol 2005, 22:83-92.
• [6]Ellis D: Amphotericin B: spectrum and resistance. J Antimicrob Chemother 2002, 49:7-10.
• [7]Lewington A: Medicinal plants and plant extracts: A review of their importation into Europe. Cambridge, United Kingdom: Traffic International; 1993.
• [8]Bibitha B, Jisha VK, Salitha CV, Mohan S, Valsa AK: Antibacterial activity of different plant extracts: A short communication. Indian J Microbiol 2002, 42:361-363.
• [9]Thangavelu R, Sundararaju P, Sathiamoorthy S: Management of anthracnose disease of banana caused by Colletotrichum musae using plant extacts. J Hortic Sci Biotech 2004, 79:664-668.
• [10]Maghrani M, Zeggwagh NA, Haloui M, Eddouks M: Acute diuretic effect of aqueous extract of Retama raetam in normal rats. J Ethnopharmacol 2005, 99:31-35.
• [11]Subeki , Matsuura H, Takahashi K, Nabeta K, Yamasaki M, Maede Y, Katakura K: Screening of Indonesian medicinal plant extracts for antibabesial activity and isolation of new quassinoids from Brucea javanica. J Nat Prod 2007, 70:1654-1657.
• [12]Chang HM, But PP: “Yadanzi”. Pharmacology and Applications of Chinese Materia Medica. Vol II. Singapore: World Scientific Pub. Co.; 1987.
• [13]Lau FY, Chui CH, Gambari R, Kok SH, Kan KL, Cheng GY, Wong RS, Teo IT, Cheng CH, Wan TS, Chan AS, Tang JC: Antiproliferative and apoptosis-inducing activity of Brucea javanica extract on human carcinoma cells. Int J Mol Med 2005, 16:1157-1162.
• [14]Himratul-Aznita WH, Mohd-Al-Faisal N, Fathilah AR: Determination of the percentage inhibition of diameter growth (PIDG) of Piper betle crude aqueous extract against oral Candida species. J Med Plant Res 2011, 5:878-884.
• [15]Bauer AW, Kirby WMM, Sherris JC, Turck M: Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol 1966, 45:493-496.
• [16]Jorgensen JH, Turnidge JD, Washington JA: Antibacterial susceptibility tests: dilution and disk diffusion methods. In Manual of Clinical Microbiology. 7th edition. Edited by Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH. Washington DC: American Society for Microbiology Press; 1999:1526-1562.
• [17]Espinel-Ingroff A, Forthergill A, Peter J, Rinaldi MG, Walsh TJ: Testing conditions for determination of minimum fungicidal concentrations of new and established antifungal agents for Aspergillus spp.: NCCLS Collaborative Study. J Clin Microbiol 2002, 40:3204-3208.
• [18]Meletiadis J, Meis JF, Mouton JW, Verweij PE: Analysis of growth characteristic of filamentous fungi in different nutrient media. J Clin Microbiol 2001, 39:478-484.
• [19]Gerhardt P, Murray RGE, Costilow RN, Nester EW, Wood WA, Krieg NR, Phillips GB: Manual of Methods for General Bacteriology. 1st edition. Washington, DC: American Society for Microbiology; 1981.
• [20]Cappuccino JG, Sherman N: Microbiology: A Laboratory Manual. 7th edition. San Fransisco, CA: Benjamin Cummings; 2005.
• [21]Rios JL, Recio MC: Medicinal plants and antimicrobial activity. J Ethnopharmacol 2005, 100:80-84.
• [22]Philip K, Malek SNA, Sani W, Shin SK, Kumar S, Lai HS, Serm LG, Rahman SNSA: Antimicrobial activity of some medicinal plants from Malaysia. Am J Appl Sci 2009, 6:1613-1617.
• [23]Tan ML: Philippine medicinal plants in common use: their phytochemistry and pharmacology. Quenzon City, Philippines: AKAP; 1980.
• [24]Fathilah AR, Rahim ZHA, Othman Y, Yusoff M: Bacteriostatic effect of Piper betle and Psidium guajava extracts on dental plaque bacteria. Pak J Biol Sci 2009, 12:518-521.
• [25]Skidmore AM, Dickinson CH: Colony interactions and hyphal interference between Septoria nodorum and phylloplane fungi. T Brit Mycol Soc 1976, 66:57-64.
• [26]Chang HC, Chang JJ, Huang AH, Chang TC: Evaluation of a capacitance method for direct antifungal susceptibility testing of yeasts in positive blood cultures. J Clin Microbiol 2000, 38:971-976.